Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice
European Thyroid Journal · 18.11.2026
DOI: 10.1530/etj-26-0352 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 18.11.2026. Verfasst von Meike Helms und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Biochemie und Molekularbiologie, Medizinische Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn , Bonn, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Monocarboxylate transporter 8 (MCT8) is essential for cellular thyroid hormone (TH) transport, and pathogenic variants cause Allan–Herndon–Dudley syndrome (AHDS). We aimed to investigate how the MCT8P253L point mutation, corresponding to human MCT8P321L, affects cerebral TH metabolism in mice and to evaluate whether the chemical chaperone sodium phenylbutyrate (NaPB) can modulate TH uptake and transporter expression in primary astrocytes, thereby providing insight into potential therapeutic strategies for MCT8 deficiency.
Methods
Mct8P253L/y mice were analyzed for Dio2 mRNA expression and DIO2 enzyme activity as markers of local TH status. Primary astrocytes from mutant and wild-type mice were used to assess T3 and T4 uptake and TH transporter expression after NaPB treatment, combining 3′-mRNA sequencing and mass spectrometry.
Results
Mct8P253L/y mice exhibited markedly increased DIO2 activity, consistent with cerebral hypothyroidism, whereas Dio2 mRNA levels remained unchanged. In primary astrocytes, NaPB did not restore MCT8P253L protein expression or T3 uptake but selectively increased T4 uptake. Mass spectrometry revealed that this effect was mediated by NaPB-induced upregulation of the alternative T4 transporter OATP1C1. Accordingly, T4 uptake was not increased in Oatp1c1-deficient astrocytes. NaPB treatment also elevated Slc16a2 and Slco1c1 transcript levels, although the underlying mechanisms remain to be elucidated.
Conclusion
NaPB enhances astrocytic T4 uptake in Mct8P253L/y mice via induction of OATP1C1 independently of MCT8 restoration. While OATP1C1 expression at the adult human blood–brain barrier is limited, NaPB may induce alternative TH transporters in glial or endothelial cells, suggesting potential therapeutic benefit for patients with MCT8 deficiency.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut für Biochemie und Molekularbiologie, Medizinische Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn , Bonn, Germany.
ORCID-Profile: Doreen Braun
Zitieren
APA
Helms, M., Schlimbach, J., Dall, E., Schweizer, U., & Braun, D. (2026). Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice. European Thyroid Journal. https://doi.org/10.1530/etj-26-0352
Vancouver
Helms M, Schlimbach J, Dall E, Schweizer U, Braun D. Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice. European Thyroid Journal. 2026. doi:10.1530/etj-26-0352
BibTeX
@article{Helms2026,
author = {Helms, Meike and Schlimbach, Joana and Dall, Esther and Schweizer, Ulrich and Braun, Doreen},
title = {Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice},
journal = {European Thyroid Journal},
year = {2026},
doi = {10.1530/etj-26-0352}
}
EUVIMED